Skip to main content
. 2022 Aug 25;14(9):1771. doi: 10.3390/pharmaceutics14091771

Figure 4.

Figure 4

(A) Overlay plot generated by graphical optimization, indicating the pink area as the design space and the flagged mark as the optimized RLX/NRG NLCs. (B) Overall desirability value.